152 related articles for article (PubMed ID: 30182340)
1. CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report.
Del Gobbo A; Fusco N; Barella M; Ercoli G; Sciarra A; Palleschi A; Pagni F; Marchiò C; Papotti M; Ferrero S
Cell Oncol (Dordr); 2018 Dec; 41(6):687-691. PubMed ID: 30182340
[TBL] [Abstract][Full Text] [Related]
2. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
[TBL] [Abstract][Full Text] [Related]
4. The oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung.
Del Gobbo A; Vaira V; Guerini Rocco E; Palleschi A; Bulfamante G; Ricca D; Fiori S; Bosari S; Ferrero S
J Thorac Oncol; 2014 Nov; 9(11):1656-61. PubMed ID: 25144243
[TBL] [Abstract][Full Text] [Related]
5. Spread through air spaces (STAS) is a predictor of poor outcome in atypical carcinoids of the lung.
Altinay S; Metovic J; Massa F; Gatti G; Cassoni P; Scagliotti GV; Volante M; Papotti M
Virchows Arch; 2019 Sep; 475(3):325-334. PubMed ID: 31201506
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases.
Righi L; Volante M; Tavaglione V; Billè A; Daniele L; Angusti T; Inzani F; Pelosi G; Rindi G; Papotti M
Ann Oncol; 2010 Mar; 21(3):548-555. PubMed ID: 19759190
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
8. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.
Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES
Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545
[TBL] [Abstract][Full Text] [Related]
9. Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.
Cusumano G; Fournel L; Strano S; Damotte D; Charpentier MC; Galia A; Terminella A; Nicolosi M; Regnard JF; Alifano M
Lung; 2017 Dec; 195(6):789-798. PubMed ID: 29022070
[TBL] [Abstract][Full Text] [Related]
10. Complexin-2 (CPLX2) as a potential prognostic biomarker in human lung high grade neuroendocrine tumors.
Komatsu H; Kakehashi A; Nishiyama N; Izumi N; Mizuguchi S; Yamano S; Inoue H; Hanada S; Chung K; Wei M; Suehiro S; Wanibuchi H
Cancer Biomark; 2013; 13(3):171-80. PubMed ID: 23912489
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
[TBL] [Abstract][Full Text] [Related]
12. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
[TBL] [Abstract][Full Text] [Related]
13. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
[TBL] [Abstract][Full Text] [Related]
14. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.
Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF
Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
16. ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature.
La Rosa S; Volante M; Uccella S; Maragliano R; Rapa I; Rotolo N; Inzani F; Siciliani A; Granone P; Rindi G; Dominioni L; Capella C; Papotti M; Sessa F; Imperatori A
Virchows Arch; 2019 Nov; 475(5):587-597. PubMed ID: 31264037
[TBL] [Abstract][Full Text] [Related]
17. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
Dermawan JKT; Farver CF
Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modifications of histone h4 in lung neuroendocrine tumors.
Li F; Ye B; Hong L; Xu H; Fishbein MC
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):389-94. PubMed ID: 21415707
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
